Cogent Biosciences (COGT) EPS (Basic) (2017 - 2020)
Historic EPS (Basic) for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$8.61.
- Cogent Biosciences' EPS (Basic) fell 295628.67% to -$8.61 in Q4 2020 from the same period last year, while for Sep 2021 it was -$0.29, marking a year-over-year increase of 9577.36%. This contributed to the annual value of -$2.16 for FY2025, which is N/A changed from last year.
- Latest data reveals that Cogent Biosciences reported EPS (Basic) of -$8.61 as of Q4 2020, which was down 295628.67% from -$5.07 recorded in Q3 2020.
- In the past 5 years, Cogent Biosciences' EPS (Basic) ranged from a high of $0.3 in Q4 2019 and a low of -$8.61 during Q4 2020
- Its 4-year average for EPS (Basic) is -$1.35, with a median of -$0.62 in 2017.
- Its EPS (Basic) has fluctuated over the past 5 years, first surged by 20394.49% in 2019, then crashed by 295628.67% in 2020.
- Cogent Biosciences' EPS (Basic) (Quarter) stood at -$0.66 in 2017, then surged by 56.06% to -$0.29 in 2018, then soared by 203.94% to $0.3 in 2019, then plummeted by 2956.29% to -$8.61 in 2020.
- Its last three reported values are -$8.61 in Q4 2020, -$5.07 for Q3 2020, and -$0.95 during Q2 2020.